Zobrazeno 1 - 10
of 22
pro vyhledávání: '"János Révész"'
Autor:
Andrea Furka, Zsofia Nagy, Imre Szabó, Gábor Fekete, Ágnes Kelemen, Gábor Bolobás, Gábriel Sebők, Tünde Molnár, János Árvai, Ilona Tornyi, László Kostyál, János Révész, Peter Hauser
Publikováno v:
Children, Vol 9, Iss 11, p 1740 (2022)
Background: Total body irradiation (TBI) 2 × 2 Gy for 3 consecutive days followed by chemotherapy for conditioning pediatric patients with acute lymphoid leukemia (ALL) before bone marrow transplantation is superior to chemo-conditioning alone. The
Externí odkaz:
https://doaj.org/article/3c990d39b6cd49cea721e86113a75998
Autor:
Anikó Maráz, Adrienn Cserháti, Gabriella Uhercsák, Éva Szilágyi, Zoltán Varga, János Révész, Renáta Kószó, Linda Varga, Zsuzsanna Kahán
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-12 (2018)
Abstract Background In patients with metastatic renal cell cancer, based on limited evidence, increased sunitinib exposure is associated with better outcome. The survival and toxicity data of patients receiving individualized dose escalated sunitinib
Externí odkaz:
https://doaj.org/article/db5ea6401a0a4868bae9430a4b6c2c44
Autor:
Koji Kawai, Satoshi Nagamori, Katherine M Bell-McGuinn, Cristiano Ferrario, Wen Pin Su, Isabel Syndikus, Aude Flechon, Georgios Gakis, Timothy Dudley Clay, Leticia Vazquez Cortés, Ronald de Wit, Florence Joly, Bozena Sikora-Kupis, Sergio Bracarda, Astra M. Liepa, Annemie Rutten, Daniel P. Petrylak, Su Peng Yeh, Annamaria Zimmermann, Sameera R. Wijayawardana, Mutsushi Kawakita, Siobhan Ng, Thean Hsiang Tan, Chikara Ohyama, Yu Jung Kim, Yuriy Golovko, Dimitrios Mavroudis, Jian Ri Li, Reinoud J. B. Blaisse, Mustafa Erman, Francesca Russo, Catherine Becht, Anghel Adrian Udrea, Robert Huddart, Syed A. Hussain, Fransiscus L.G. Erdkamp, Satoshi Fukasawa, Francesco Massari, Motohide Uemura, Boris Alekseev, Irfan Cicin, Se Hoon Park, Marcello Tucci, Lajos Géczi, Maureen J.B. Aarts, Yu Li Su, Fumimasa Fukuta, Hyo Jin Lee, Wolfgang Schultze-Seemann, Alexandra Drakaki, Hakan Harputluoglu, Xavier Garcia del Muro, Santhanam Sundar, Avivit Peer, Herlinde Dumez, William E. Lawler, Juan Ignacio Delgado Mignorance, Naveed Sarwar, Jeanny B. Aragon-Ching, Benjamin T. Herms, Fredrik Laestadius, Nobuaki Matsubara, Ivan Sinielnikov, Cora N. Sternberg, Hiroyuki Nishiyama, Piotr Tomczak, Brigitte Laguerre, Rebecca R. Hozak, Vasilis Karavasilis, Christina A. Schwentner, Hiroyuki Tsunemori, Masayoshi Nagata, Igor Bondarenko, Andrea Necchi, Yen Chuan Ou, Scott T. Tagawa, Constance Thibault, Richard A. Walgren, Akira Yokomizo, Evan Y. Yu, Alejo Rodriguez-Vida, Sufia Safina, Ulka N. Vaishampayan, János Révész, Aristotelis Bamias, Jae-Lyun Lee, Chien Liang Lin, Thomas W. Flaig, Roman Fomkin, Petr Alexandrovich Karlov, Joanna Wojcik-Tomaszewska, Junichi Inokuchi, Wataru Obara, Haralambos Kalofonos, John D. Hainsworth, Marc-Oliver Grimm, Thomas Eugene Lowe, Pablo Gajate Borau, Simon J. Crabb, Lisa Sengeloev, Junji Yonese, Simon Chowdhury, Elizabeth Jane Hovey, Daniel Castellano, Peter Istvan Acs, Chia-Chi Lin, Claudia Lorena Urzua Flores, Jean-Pascal Machiels, Kim N. Chi, Takahiro Osawa, Nobuo Shinohara, Daniel Kejzman, Günter Niegisch, David Sarid, Yuksel Urun, Yun Gyoo Lee, Oday Hamid, Alina Amalia Herzal, Michael Schenker, Eli Rosenbaum, Enrique Grande, Raya Leibowitz-Amit, Naoto Miyajima, Michiel S. van der Heijden, Shinichi Yamashita, Susanna Yee Shan Cheng, Kazuo Nishimura, Sun Young Rha, Thomas Powles, Hasan Şenol Coşkun, Jens Bedke, Ivor J. Percent, Christos Papandreou, James K. Schwarz, Masafumi Oyama, Giorgio V. Scagliotti, Chong-Xian Pan, Yoshihiko Tomita, Giampaolo Tortora, Stéphane Culine, Suet Lai Shirley Wong, Andrey Semenov, Jennifer L. Cultrera, Niels Viggo Jensen, Michael Stöckle, Katsuyoshi Hashine
Publikováno v:
Lancet Oncology, 21(1), 105-120. Lancet Publishing Group
The Lancet. Oncology, Vol. 21, no.1, p. 105-120 (2020)
Lancet oncology, 21(1), 105-120. Elsevier Science
lancet oncology, 21(1), 105-120. Lancet Publishing Group
The Lancet. Oncology, Vol. 21, no.1, p. 105-120 (2020)
Lancet oncology, 21(1), 105-120. Elsevier Science
lancet oncology, 21(1), 105-120. Lancet Publishing Group
Background Ramucirumab-an IgG1 vascular endothelial growth factor receptor 2 antagonistplus docetaxel was previously reported to improve progression-free survival in platinum-refractory, advanced urothelial carcinoma. Here, we report the secondary en
Autor:
Erika Hartmann, Zoltán Lóderer, András Vereczkei, György Lázár, Tamás Györke, György Bodoky, Zsuzsanna Papai, Péter Pajor, Oszkár Hahn, Barna Bogner, Károly Kalmár Nagy, Klára Mezei, Elemér Mohos, Zsolt Horváth, Eszter Székely, Magdolna Dank, Attila Doros, P. Á. Deák, Zsuzsa Schaff, Marianna Imre, István Sipőcz, Edit Dósa, Mihály Patyánik, László Mangel, László Harsányi, Péter Kupcsulik, I. Dudás, Péter Bartek, Kristóf Dede, András Papp, Ágnes Ruzsa, Zsolt Káposztás, József Lövey, István Battyáni, Laszlo Torday, Tamás Mersich, Attila Szijártó, Zoltan Mathe, László Sikorszki, László Damjanovich, Krisztina Schlachter, János Révész, Csilla András, Lajos Tóth, László Landherr, János Bezsilla, Erika Hitre, Tibor Csőszi, Zsófia Dankovics, Gábor István, András Palkó, Attila Bursics, András Petri, Ákos Szűcs, László Kóbori, Attila Oláh
Publikováno v:
Orvosi Hetilap. 160:2-20
Autor:
Andrea Furka, Csaba Simkó, László Kostyál, Imre Szabó, Anikó Valikovics, Gábor Fekete, Ilona Tornyi, Endre Oross, János Révész
Publikováno v:
Cancers. 14:1203
Background: In advanced cancer stage the incidence of cancerous wounds is about 5%, and the estimated life expectancy is not more than 6 to 12 months. Without interdisciplinary and individualized treatment strategy, symptoms progress, and adversely i
Publikováno v:
Orvosi Hetilap. 159:1317-1325
Abstract: Introduction: Mortality of prostate carcinoma can be significantly decreased by the use of modern diagnostic and therapeutic options. Patients in early stages can be cured by radical surgery or radiotherapy. Aim: Overview and comparison of
Autor:
Miklós Szűcs, Zsuzsanna Kahán, János Révész, Lajos Géczi, Zoltán Varga, Magdolna Dank, Judit Kocsis, András Csejtei, László Mangel, Anikó Maráz, György Bodoky
Publikováno v:
Pathology & Oncology Research. 25:149-156
Everolimus is indicated for adults with metastatic renal cell carcinoma (mRCC) after failure of vascular endothelial growth factor receptor-tyrosine kinase inhibitors (TKI). Currently, the therapeutic applicability of EVE has been changing. Multicent
Autor:
LÁSZLÓ, LANDHERR, TAMÁS, PINTÉR, LAJOS, HORNYÁK, JÁNOS, RÉVÉSZ, KÁROLY, MÁHR, LÁSZLÓ, TORDAY, CSILLA, ANDRÁS, JÓZSEF, ERFÁN, PÉTER, ÁRKOSY, GYÖRGY, BODOKY
Publikováno v:
Magyar Onkologia; 2022, Vol. 66 Issue 1, p11-19, 9p
Publikováno v:
Orvosi hetilap. 159(32)
Mortality of prostate carcinoma can be significantly decreased by the use of modern diagnostic and therapeutic options. Patients in early stages can be cured by radical surgery or radiotherapy.Overview and comparison of previous and present diagnosti
Autor:
Levente Kuthi, Ibolya Laczó, Linda Varga, János Révész, Réka Kránicz, Boglárka Pósfai, Anikó Maráz
Publikováno v:
Anticancer research. 38(6)
Background Neuroendocrine neoplasms include a heterogeneous group of malignant tumors. Primary neuroendocrine tumors in the genitourinary tract are rare, comprising approximately 1-2% of genitourinary malignancies. Materials and methods An extensive